78.44
전일 마감가:
$78.21
열려 있는:
$78.8
하루 거래량:
44,732
Relative Volume:
0.06
시가총액:
$4.33B
수익:
$1.43B
순이익/손실:
$107.13M
주가수익비율:
40.49
EPS:
1.9372
순현금흐름:
$161.04M
1주 성능:
-4.54%
1개월 성능:
-1.70%
6개월 성능:
+14.71%
1년 성능:
+48.48%
Livanova Plc Stock (LIVN) Company Profile
명칭
Livanova Plc
전화
4402033250662
주소
20 EASTBOURNE TERRACE, LONDON
Compare LIVN vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
LIVN
Livanova Plc
|
78.52 | 4.45B | 1.43B | 107.13M | 161.04M | 1.9372 |
|
ABT
Abbott Laboratories
|
115.49 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
329.36 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
92.48 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
49.81 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
89.97 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-19 | 개시 | KeyBanc Capital Markets | Overweight |
| 2025-10-01 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-05-20 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | 개시 | Goldman | Buy |
| 2024-09-17 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | 재확인 | Needham | Buy |
| 2024-02-20 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-09-06 | 개시 | HSBC Securities | Hold |
| 2023-07-19 | 개시 | Robert W. Baird | Neutral |
| 2023-04-14 | 개시 | Mizuho | Neutral |
| 2022-12-21 | 개시 | Barclays | Equal Weight |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-02-24 | 업그레이드 | UBS | Neutral → Buy |
| 2021-12-03 | 개시 | Goldman | Buy |
| 2021-08-20 | 재확인 | Needham | Buy |
| 2021-07-20 | 업그레이드 | Needham | Hold → Buy |
| 2021-03-03 | 다운그레이드 | Berenberg | Buy → Hold |
| 2021-01-05 | 다운그레이드 | Needham | Buy → Hold |
| 2020-09-02 | 개시 | Robert W. Baird | Outperform |
| 2020-06-26 | 재확인 | Needham | Buy |
| 2019-10-30 | 재확인 | Needham | Buy |
| 2019-02-28 | 재확인 | Needham | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-06-08 | 개시 | Stifel | Buy |
| 2018-05-31 | 재확인 | Needham | Buy |
| 2018-02-28 | 재확인 | Needham | Buy |
모두보기
Livanova Plc 주식(LIVN)의 최신 뉴스
LIVN Looks 23.4% Overvalued on GF Value™ - GuruFocus
LivaNova (NASDAQ:LIVN) Downgraded by Zacks Research to "Hold" - MarketBeat
LivaNova PLC (LIVN) Stock Down 3.3% but Still Overvalued -- GF S - GuruFocus
Anne Liddy Joins LivaNova as Chief Legal Officer - Medical Product Outsourcing
LivaNova (NASDAQ:LIVN) Gains Attention After Strong Results - Kalkine Media
LivaNova PLC (NASDAQ:LIVN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
LivaNova (LIVN) End-of-Day Review: Ends Down by 1.99% at $79.86 for the Current Session; Trading Range: the Price Remains Bounded by the Supplied Support and Resistance at the CloseDip Buy Trade - Vinanet
LivaNova (LIVN) Reported Quarter: Profit Per Share Surpasses Its Benchmark at the Close; Share-Price Check: Shares Move 1.57% Lower in the Available RecordNegative Surprise Momentum - Vinanet
LivaNova (NASDAQ:LIVN) Combines Strong Growth With a Promising Technical Breakout Setup - ChartMill
LivaNova (LIVN) Q2 2026 Earnings Call Transcript - AOL.com
LivaNova PLC $LIVN Stake Lessened by Bank of America Corp DE - MarketBeat
Ahmet Tezel Executes Sell Order: Offloads $876K In LivaNova Stock - Benzinga
LivaNova CIO Ahmet Tezel Reports Stock Transactions and Ownership Update - Kalkine Media
LivaNova PLC (LIVN) Stock forecasts - Yahoo Finance UK
LivaNova (LIVN) executive exercises 12,692 SARs and disposes shares - Stock Titan
Stronger Q2 Results And New Supply Deal Might Change The Case For Investing In LivaNova (LIVN) - Yahoo Finance
LivaNova (LIVN) Could Be 5% Undervalued Following Raised 2026 Guidance - Yahoo Finance
LivaNova PLC (LIVN) employee stock rights lead to 2,675-share sale - Stock Titan
LivaNova PLC (LIVN) Stock Forecasts - Yahoo! Finance Canada
LivaNova (LIVN) Is Down 7.6% After Swinging Back To Profitability In Q2 2026What's Changed - webull.com
LivaNova PLC at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Q3 2025 LivaNova PLC Earnings Call Transcript - GuruFocus
LivaNova PLC $LIVN Shares Purchased by Quantinno Capital Management LP - MarketBeat
Price to earnings forward of LivaNova Plc – FWB:LIA - TradingView
LivaNova revenue increases 10.8% in Q2 2026 - medicalbuyer.co.in
LivaNova PLC (LIVN) Stock News Today - TradingKey
LivaNova PLC (LIA) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
LivaNova PLC (LIA) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
LivaNova Q2 Earnings & Revenues Beat Estimates, '26 Outlook Raised - Zacks Investment Research
LivaNova Sees Solid Demand in Both Cardiopulmonary and Neuromodulation - Morningstar
FMR LLC (LIVN) discloses 5.8% LivaNova stake in Schedule 13G filing - Stock Titan
LivaNova (NASDAQ:LIVN) Releases Quarterly Earnings Results, Beats Estimates By $0.17 EPS - MarketBeat
Livanova stock price target raised to $93 by Needham on guidance - Investing.com UK
LivaNova PLC (LIVN) Shares Fall 8.5% -- GF Value Says Still Over - GuruFocus
LivaNova PLC (LIVN) (Q2 2026) Earnings Call Highlights: Record R - GuruFocus
LivaNova PLC Q2 2026 Earnings Call Summary - Yahoo Finance
LivaNova PLC Stock 12‑Month Price Target Raised to $88.78, Implies 4% Upside - TradingView
LivaNova PLC 2026 Q2ResultsEarnings Call Presentation (NASDAQ:LIVN) 2026-08-05 - Seeking Alpha
LIVN Maintained by Needham -- Price Target Raised to $93 - GuruFocus
Earnings call transcript: LivaNova tops Q2 2026 estimates and lifts outlook - Investing.com Nigeria
LivaNova PLC (LIVN) (Q2 2026) Earnings Call Highlights: Record Revenue and EPS, Raised Guidance ... - Yahoo Finance
LivaNova PLC SEC Filing (Aug 5, 2026) - Stock Titan
Needham & Company LLC Forecasts Strong Price Appreciation for LivaNova (NASDAQ:LIVN) Stock - MarketBeat
LivaNova Q2 Earnings Call Highlights - MarketBeat
LivaNova Releases Q2 2026 Financial Results - AlphaStreet
LivaNova PLC reports results for the quarter ended June 30Earnings Summary - TradingView
LivaNova (LIVN) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
LivaNova PLC (LIVN) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
LIVN Looks 36.1% Overvalued on GF Value™ as Insider Selling and Guru Activity Signal Caution - GuruFocus
Is LivaNova PLC (LIVN) Overvalued After Q2 Earnings Beat? EPS at $1.93, Revenue $390.6M -- GF Score: 74/100 - GuruFocus
LivaNova PLC Raises Earnings Guidance for the Full Year 2026 - marketscreener.com
Livanova Plc (LIVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Livanova Plc 주식 (LIVN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Tezel Ahmet | Chief Innovation Officer |
Aug 11 '26 |
Sale |
77.74 |
2,675 |
207,942 |
6,090 |
자본화:
|
볼륨(24시간):